News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BeiGene Plans a $100 Million to $150 Million Capital Raise


7/11/2011 8:09:26 AM

July 8, 2011 -- BeiGene, the Beijing area oncology startup, said it expects to raise between $100 million and $150 million this year from a group of up to seven biopharmas and venture capitalists. In May, the company announced it received backing from Merck, though it didn’t disclose the size of the financing. At the time, CEO John Oyler told ChinaBio® Today that the Merck financing did not prohibit BeiGene from seeking backing from other pharmas, an important provision. More details....

Stock Symbol: (NYSE: MRK)


Read at ChinaBio Today

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES